Analyst firms · H.C. Wainwright · TGTX
H.C. Wainwright TGTX price target and rating history
TG Therapeutics Inc. (TGTX) · Health Care
H.C. Wainwright rates TG Therapeutics Inc. (TGTX) Buy with a $60 price target, as of its latest action on Oct 6, 2025. It has published 5 rating actions on TGTX since August 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Buy
- Price target
- $60
- Median target, all firms
- Too few
- Actions on TGTX
- 5
H.C. Wainwright price target on TGTX
Every H.C. Wainwright rating on TGTX
- Oct 6, 2025
- Jan 28, 2022
- Jan 24, 2022
- Dec 1, 2021
- Aug 2, 2021
Questions about H.C. Wainwright and TGTX
- What is H.C. Wainwright's price target for TGTX?
- H.C. Wainwright's latest stated price target for TG Therapeutics Inc. (TGTX) is $60, from its action on Oct 6, 2025.
- What is H.C. Wainwright's rating on TGTX?
- H.C. Wainwright rates TGTX Buy, a bullish rating, as of Oct 6, 2025.
- When did H.C. Wainwright last change its view on TGTX?
- On Oct 6, 2025, H.C. Wainwright resumes coverage at Buy, price target $60.
More TGTX rating histories
All H.C. Wainwright ratingsTGTX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.